Spelling suggestions: "subject:"5hydroxytryptophan"" "subject:"5hydroxytryptophane""
1 |
Chronic reserpine and depression: potentiated 5-hydroxytryptophan induced behavioral depression in rats following chronic reserpineBrugge, Karen L. January 1988 (has links)
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
|
2 |
Serotonin receptor subtypes and central effects mediating 5-hydroxytryptophan induced operant response suppression in an animal model of depressionEngleman, Eric Andrew January 1992 (has links)
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
|
3 |
Serotonergic Modulation of the Crayfish Hindgut: Effects on Hindgut Contractility and Regulation of Serotonin on HindgutMusolf, Barbara Ellen 28 November 2007 (has links)
Serotonin (5-hydroxytryptamine, 5-HT) has long been associated with the vertebrate gut and is an important neuromodulator of crustacean foregut. This dissertation presents evidence that 5-HT initiated peristalsis in crayfish hindgut and enhanced the power of contractions in caudal regions of the hindgut. 5-HT receptor immunoreactivity studies showed that the two identified crustacean 5-HT receptors, 5-HT1α and 5-HT2β are present on the hindgut in different and distinctive patterns. 5-HT immunoreactivity (5-HT-ir) studies revealed that the fibers from central neurons found on the hindgut showed a broad range of 5-HT-ir intensity, which led to the hypothesis that they borrowed 5-HT. This hypothesis was tested by first determining that the HGNs can take up 5-HT through a serotonin transporter and that uptake can be blocked by a serotonin reuptake inhibitor. Second, synthesis was tested by superfusing tryptophan and using 5-HT-ir to determine the presence of 5-HT. No constitutive 5-HT synthesis occurred under these conditions. Superfusion of the intermediate product of 5-HT synthesis, 5-hydroxytryptophan (5-HTP), did lead to 5-HT-ir. The HGNs can take up 5-HT but have only one of the synthetic enzymes. The lack of nearby sources for 5-HT led to the hypothesis that hormonally supplied 5-HT may be the source for 5-HT in the HGNs. High performance liquid chromatography measurements of 5-HT and 5-HTP levels in tissue following injection of 5-HT into the hemolymph revealed that levels of 5-HT significantly increased in the terminal ganglion and hindgut, where the HGNs cell bodies and projections are respectively located. All other areas of the central nervous system, with the exception of the brain, also showed a significant increase in 5-HT levels. Injection of tryptophan produced a significant increase in 5-HTP levels in the brain. Quantitative 5-HT-ir indicated that feeding increased the intensity of 5-HT-ir in the HGNs. Feeding was determined to be a relevant stimulus to examine facultative synthesis of 5-HT. The enzyme that converts 5-HT to 5-HTP was blocked and 48 hrs after feeding 5-HTP-ir was used to indicate that facultative synthesis did not occur. At the same time, 5-HT-ir was used to indicate that uptake of 5-HT by the HGNs more likely occurred.
|
4 |
Liquid chromatography-mass spectrometry study of two biochemical alcohol markers /Stephanson, Niclas Nikolai, January 2007 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.
|
5 |
Analysis of Clinically Important Compounds Using Electrophoretic Separation Techniques Coupled to Time-of-Flight Mass SpectrometryPeterson, Zlatuse Durda 16 April 2004 (has links)
Capillary electrophoretic (CE) separations were successfully coupled to time-of-flight mass spectrometric (TOFMS) detection for the analysis of three families of biological compounds that act as mediators and/or indicators of disease, namely, catecholamines (dopamine, epinephrine, norepinephrine) and their O-methoxylated metabolites (3-methoxytyramine, norepinephrine, and normetanephrine), indolamines (serotonin, tryptophan, and 5-hydroxytryptophan), and angiotensin peptides. While electrophoretic separation techniques provided high separation efficiency, mass spectrometric detection afforded specificity unsurpassed by other types of detectors. Both catecholamines and indolamines are present in body fluids at concentrations that make it possible for them to be determined by capillary zone electrophoresis coupled to TOFMS without employing any preconcentration scheme beyond sample work up by solid phase extraction (SPE). Using this hyphenated approach, submicromolar levels of catecholamines and metanephrines in normal human urine and indolamines in human plasma were detected after the removal of the analytes from their biological matrices and after preconcentration by SPE on mixed mode cation-exchange sorbents. The CE-TOFMS and SPE methods were individualized for each group of compounds. While catecholamines and metanephrines in urine samples were quantitated using 3,4-dihydroxybenzylamine as an internal standard, deuterated isotopes, considered ideal internal standards, were used for the quantitation of indolamines. Because the angiotensin peptides are present in biological fluids at much lower concentrations than the previous two families of analytes, their analysis required the application of additional preconcentration techniques. In this work, the coupling of either of two types of electrophoretic preconcentration methods - field amplified injection (FAI) and isotachophoresis (ITP) - to capillary zone electrophoresis with both UV and MS detection was evaluated. Using FAI-CE-UV, angiotensins were detected at ~1 nM concentrations. Using similar conditions but TOFMS detection, the detection limits were below 10 nM. ITP was evaluated in both single-column and two-column comprehensive arrangements. The detection limits achieved for the ITP-based techniques were approximately one order of magnitude higher than for the FAI-based preconcentration. While the potential usefulness of these techniques was demonstrated using angiotensins standards, substantial additional research would be required to allow these approaches to be applied to plasma as part of clinical assays.
|
6 |
Studies on Premenstrual DysphoriaEriksson, Olle January 2005 (has links)
<p>Premenstrual dysphoria, so severe that it affects the lives of the women afflicted, is the condition studied in this thesis. Physiological and pharmacological mechanisms of pathogenetic relevance were investigated. </p><p>Women with premenstrual dysphoria showed a stronger and less dampened response of LH to an estradiol challenge than asymptomatic women, indicating an altered neuroendocrine regulation. In women with premenstrual dysphoria, the LH response was correlated to the severity of irritability and bloating, and the early FSH response was correlated to the severity of depressed mood. </p><p>The positron-emission study showed strong, consistent correlations between worsening of mood symptoms and a decrease in brain trapping of the immediate serotonin precursor, from the mid-follicular to the late luteal phase in women with premenstrual dysphoria. The strongest correlations were seen for the cardinal mood symptoms of premenstrual dysphoria, and for their opposites. Physical symptoms showed weaker or no correlations with the exception of nociceptive symptoms from erogenous body regions which showed positive correlations to serotonin precursor trapping in the right caudate nucleus. The findings are consistent with the serotonin hypothesis of premenstrual dysphoria, and might possibly explain the observed effects of serotonin-augmenting drugs in this condition.</p><p>The partial 5-HT<sub>1A</sub> receptor agonist buspirone was superior to placebo in the treatment of premenstrual dysphoria. The weak SRI and 5-HT<sub>2</sub> receptor antagonist nefazodone was not superior to placebo. For women with premenstrual dysphoria in need of medication and who do not tolerate SRIs because of the sexual sideeffects, buspirone may be an alternative drug, since it had no adverse effects on sexual function. </p><p>The prevalence of polycystic ovaries and serum levels of androgens were not higher in women with premenstrual dysphoria than in their asymptomatic counterparts. The findings are not consistent with the hypothesis that irritability in women with premenstrual dysphoria is induced by elevated testosterone levels. </p><p>Thesis results, which are in line with the serotonin hypothesis of premenstrual dysphoria, may imply that increased brain sensitivity is one of the factors underlying severe premenstrual mood symptoms, thereby further supporting a common serotonergic dysregulation in this condition.</p>
|
7 |
Studies on Premenstrual DysphoriaEriksson, Olle January 2005 (has links)
Premenstrual dysphoria, so severe that it affects the lives of the women afflicted, is the condition studied in this thesis. Physiological and pharmacological mechanisms of pathogenetic relevance were investigated. Women with premenstrual dysphoria showed a stronger and less dampened response of LH to an estradiol challenge than asymptomatic women, indicating an altered neuroendocrine regulation. In women with premenstrual dysphoria, the LH response was correlated to the severity of irritability and bloating, and the early FSH response was correlated to the severity of depressed mood. The positron-emission study showed strong, consistent correlations between worsening of mood symptoms and a decrease in brain trapping of the immediate serotonin precursor, from the mid-follicular to the late luteal phase in women with premenstrual dysphoria. The strongest correlations were seen for the cardinal mood symptoms of premenstrual dysphoria, and for their opposites. Physical symptoms showed weaker or no correlations with the exception of nociceptive symptoms from erogenous body regions which showed positive correlations to serotonin precursor trapping in the right caudate nucleus. The findings are consistent with the serotonin hypothesis of premenstrual dysphoria, and might possibly explain the observed effects of serotonin-augmenting drugs in this condition. The partial 5-HT1A receptor agonist buspirone was superior to placebo in the treatment of premenstrual dysphoria. The weak SRI and 5-HT2 receptor antagonist nefazodone was not superior to placebo. For women with premenstrual dysphoria in need of medication and who do not tolerate SRIs because of the sexual sideeffects, buspirone may be an alternative drug, since it had no adverse effects on sexual function. The prevalence of polycystic ovaries and serum levels of androgens were not higher in women with premenstrual dysphoria than in their asymptomatic counterparts. The findings are not consistent with the hypothesis that irritability in women with premenstrual dysphoria is induced by elevated testosterone levels. Thesis results, which are in line with the serotonin hypothesis of premenstrual dysphoria, may imply that increased brain sensitivity is one of the factors underlying severe premenstrual mood symptoms, thereby further supporting a common serotonergic dysregulation in this condition.
|
Page generated in 0.043 seconds